7 Hot Healthcare Stocks to Buy Right Now

Page 6 of 6

1. Grifols, S.A. (NASDAQ:GRFS) 

6 Months Total Return: 21.93% 

Grifols, S.A. (NASDAQ:GRFS) tops our list for being one of the hot stocks to buy. It is headquartered in Barcelona and is a global healthcare company specializing in plasma-derived therapies, diagnostics, and hospital supplies. Its main business units, Bioscience, Diagnostics, and Hospital, focus on immunotherapy, transfusion medicine, and critical care, serving patients worldwide with treatments for bleeding disorders, immunodeficiencies, and neurological conditions. The company maintains a strong global presence across 100+ countries and leverages strategic partnerships and acquisitions to drive growth.

In mid-2025, Grifols, S.A. (NASDAQ:GRFS) announced plans to build a new manufacturing site in Spain, aimed at doubling its plasma fractionation capacity in Europe. This expansion reflects the company’s strategic commitment to scaling production capabilities to meet rising demand for plasma-based therapies. The move aligns with GRFS’ Value Creation Plan, which has supported steady revenue growth, including a reported 7% increase to EUR 3,677 million in H1 2025.

The new facility strengthens Grifols, S.A. (NASDAQ:GRFS)’ supply chain resilience and positions the company competitively in the growing plasma therapeutics market. By expanding production, the business aims to improve market share while addressing critical clinical needs in immunotherapy and transfusion medicine.

While we acknowledge the potential of GRFS to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than GRFS and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 6 of 6